Mineralys Therapeutics Q1 2024 Earnings Report

Total Revenue
$0
EPS
-$0.7
Previous year: -$0.51
+37.3%
R&D Expenses
$30.8M
G&A Expenses
$4.61M
Total Other Income, Net
$3.85M

Mineralys Therapeutics

Mineralys Therapeutics